Neurotop^®

Neurotop^® contains the active substance carbamazepine.

Carbamazepine has both a seizure-inhibiting and a mood-improving effect in various forms of epileptic seizures.

Neurotop^® is given to adults, children and adolescents for the treatment of epilepsy.

• Complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalisation.
• Generalised tonic-clonic seizures
• Mixed forms of seizures

Neurotop^® can be used for monotherapy and combination therapy.

Neurotop^® is used in adults for the treatment of acute mania and for the phase prophylaxis of manic-depressive psychoses in patients who do not respond to or for whom lithium therapy is contraindicated. Neurotop^® is also used in trigeminal neuralgia, diabetic neuropathy and to prevent cerebral seizures in alcohol withdrawal syndrome.